Business
Zimmer Biomet Increases Share Repurchase Expectations -- Up to $1 Billion by Year End
Zimmer Biomet Holdings, Inc. (NYSE and SIX: ZBH), a global medical technology leader, today announced that it now anticipates repurchasing up to $1 billion of its common stock during fiscal year 2026, a $250 million increase from the company's prior assumption.
About this update from Zimmer Biomet Holdings, Inc.
[{"type":"text","content":"WARSAW, Ind., May 12, 2026 /PRNewswire/ -- Zimmer Biomet Holdings, Inc. (NYSE and SIX: ZBH), a global medical technology leader, today announced that it now anticipates repurchasing up to $1 billion of its common stock during fiscal year 2026, a $250 million increase from the company's prior assumption.","length":318,"tagName":"p"},{"type":"image","alt":"(PRNewsfoto/Zimmer Biomet Holdings, Inc.)","displaySize":"","headline":null,"caption":"(PRNewsfoto/Zimmer Biomet Holdings, Inc.)","className":"","disableSlideshowImg":false,"size":{"original":{"width":400,"height":101,"url":"https://media.zenfs.com/en/prnewswire.com/b2006881f7d00e48739c8660384a6286"},"resized":{"url":"https://s.yimg.com/ny/api/res/1.2/hxWOdl98LZNwgawJplj_sA--/YXBwaWQ9aGlnaGxhbmRlcjt3PTcwNTtoPTE3OA--/https://media.zenfs.com/en/prnewswire.com/b2006881f7d00e48739c8660384a6286","width":400,"height":101},"resize_sm":{"url":"https://s.yimg.com/ny/api/res/1.2/n9Rs2m3hB207YwvsLIureQ--/YXBwaWQ9aGlnaGxhbmRlcjt3PTY0MDtoPTE2Mg--/https://media.zenfs.com/en/prnewswire.com/b2006881f7d00e48739c8660384a6286","width":400,"height":101}},"href":"https://mma.prnewswire.com/media/1603977/Zimmer_Biomet_Holdings_Logo.html","hrefExternal":true,"rel":"nofollow"},{"type":"text","content":"All repurchases are expected to be made under the company's existing $1.5 billion share repurchase authorization, which was approved by the Zimmer Biomet Board of Directors and announced in February 2026. The company has not made any changes to the size, duration or terms of that authorization.","length":299,"tagName":"p"},{"type":"text","content":"The company may repurchase shares in the open market and/or enter into structured repurchase agreements with third parties. The timing and actual amount of share repurchases will depend on a variety of considerations, including market conditions, the company's stock price, capital availability and alternative uses of capital.","length":331,"tagName":"p"},{"type":"text","content":"About Zimmer BiometZimmer Biomet is a global medical technology leader with a comprehensive portfolio designed to maximize mobility and improve health. We seamlessly transform the patient experience through our innovative products and suite of integrated digital and robotic technologies that leverage data, data analytics and artificial intelligence.","length":352...